Diagnos Inc
🇨🇦XTSX.ADKCanadaHealthcare
PriceCA$0.24-0.01 (-4%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 8
- Medium: 2
- Low: 0
Cash conversion cycle: a sudden spike above its trailing quarter average
Payables turnover: a sudden spike above its trailing quarter average
P/B ratio: a sudden spike above its trailing quarter average
Return on assets: a sudden drop below its trailing quarter average
Current ratio: below the level we flag as a liquidity warning
Free with a Finzer account.
Profile
- Healthcare
- Health Information Services
- Canada
Identity
- Exchange
- TSX Venture Exchange . XTSX
- Type
- Stock
- ISIN
- CA2524423068
- CUSIP
- 252442306
Company
- Employees
- 0
- Headquarters
- Brossard, Canada
- Website
- https://www.diagnos.com
Market
- Shares outstanding
- 121M
- Market cap
- CA$24.45M
Highlights
- Market cap
- CA$24.45M
- EPS LTM
- -CA$0.05calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.22calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CA$86.51K-47.1%down year on year
- Net income
- -CA$4.68M-51.8%down year on year
- Gross margin
- -1,418.21%-207.66%down year on year
- Free cash flow
- -CA$3.79M-50.15%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Diagnos Inc is a company in the healthcare sector, listed on TSX Venture Exchange (Canada) under the ticker ADK. Its market capitalisation is CA$24.45M, from 121M shares outstanding, as of . Across the 141 trading sessions to the shares traded between CA$0.23 and CA$0.42, and the last close of CA$0.24 sits 5% of the way up that range. The company is headquartered in Brossard, Canada.
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.